FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1630155892> ?p ?o ?g. }

• W1630155892 endingPage "188" @default.
• W1630155892 startingPage "178" @default.
• W1630155892 abstract "Levornidazole, which was originally used to inhibit anaerobic and protozoal infections, is currently known to possess a novel pharmacological effect. In this study, we investigated the possible modulation by levornidazole of NOD-like receptor protein 3 (NLRP3) inflammasome-mediated IL-1β and IL-18 release from macrophages. The NLRP3 inflammasome could be activated by lipopolysaccharide (LPS) plus ATP or monosodium urate (MSU) in PMA-pretreated THP-1 macrophages. Surprisingly, an in vitro study showed that levornidazole suppressed IL-1β and IL-18 secretion by blocking the activation of the NLRP3 inflammasome. However, dextrornidazole barely suppressed the NLRP3 inflammasome. Levornidazole displays activity similar to that of dextrornidazole against clinical anaerobic bacteria, and they possess the same pharmacokinetic properties. Moreover, both of these compounds were unable to ameliorate T cell-mediated inflammation. Therefore, we used the widely applied NLRP3 inflammasome-related models of dextran sodium sulfate (DSS)-induced colitis and LPS-induced endotoxin shock to confirm the novel pharmacological effect of levornidazole in vivo. The in vivo studies verified the novel activity of levornidazole because the inhibition of NLRP3 inflammasome by levornidazole contributed to a better ameliorating effect than that of dextrornidazole in the in vivo models tested. Furthermore, this inhibitory effect of levornidazole was found to be at least partially achieved by decreasing the mitochondrial ROS generation without inhibiting NF-κB activation. In summary, these data describe a new pharmacological effect of levornidazole as an inhibitor of NLRP3 inflammasome activation." @default.
• W1630155892 created "2016-06-24" @default.
• W1630155892 creator A5006890585 @default.
• W1630155892 creator A5017541508 @default.
• W1630155892 creator A5019005101 @default.
• W1630155892 creator A5043069697 @default.
• W1630155892 creator A5050409304 @default.
• W1630155892 creator A5054524412 @default.
• W1630155892 creator A5068093752 @default.
• W1630155892 creator A5074034944 @default.
• W1630155892 date "2015-09-01" @default.
• W1630155892 modified "2023-10-14" @default.
• W1630155892 title "A new pharmacological effect of levornidazole: Inhibition of NLRP3 inflammasome activation" @default.
• W1630155892 cites W1969822364 @default.
• W1630155892 cites W1979217507 @default.
• W1630155892 cites W1980560909 @default.
• W1630155892 cites W1984456316 @default.
• W1630155892 cites W1985538633 @default.
• W1630155892 cites W1987186486 @default.
• W1630155892 cites W1995721213 @default.
• W1630155892 cites W2004432444 @default.
• W1630155892 cites W2011197767 @default.
• W1630155892 cites W2014054401 @default.
• W1630155892 cites W2025036456 @default.
• W1630155892 cites W2038408646 @default.
• W1630155892 cites W2043260789 @default.
• W1630155892 cites W2044924696 @default.
• W1630155892 cites W2050614834 @default.
• W1630155892 cites W2060836319 @default.
• W1630155892 cites W2068633454 @default.
• W1630155892 cites W2074284811 @default.
• W1630155892 cites W2075927984 @default.
• W1630155892 cites W2089503694 @default.
• W1630155892 cites W2090859543 @default.
• W1630155892 cites W2097734497 @default.
• W1630155892 cites W2100578385 @default.
• W1630155892 cites W211213678 @default.
• W1630155892 cites W2121836743 @default.
• W1630155892 cites W2124178650 @default.
• W1630155892 cites W2128063282 @default.
• W1630155892 cites W2134657806 @default.
• W1630155892 cites W2137573856 @default.
• W1630155892 cites W2155660329 @default.
• W1630155892 cites W2166209782 @default.
• W1630155892 cites W4237404967 @default.
• W1630155892 doi "https://doi.org/10.1016/j.bcp.2015.06.030" @default.
• W1630155892 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26212544" @default.
• W1630155892 hasPublicationYear "2015" @default.
• W1630155892 type Work @default.
• W1630155892 sameAs 1630155892 @default.
• W1630155892 citedByCount "31" @default.
• W1630155892 countsByYear W16301558922015 @default.
• W1630155892 countsByYear W16301558922016 @default.
• W1630155892 countsByYear W16301558922017 @default.
• W1630155892 countsByYear W16301558922018 @default.
• W1630155892 countsByYear W16301558922019 @default.
• W1630155892 countsByYear W16301558922020 @default.
• W1630155892 countsByYear W16301558922021 @default.
• W1630155892 countsByYear W16301558922022 @default.
• W1630155892 countsByYear W16301558922023 @default.
• W1630155892 crossrefType "journal-article" @default.
• W1630155892 hasAuthorship W1630155892A5006890585 @default.
• W1630155892 hasAuthorship W1630155892A5017541508 @default.
• W1630155892 hasAuthorship W1630155892A5019005101 @default.
• W1630155892 hasAuthorship W1630155892A5043069697 @default.
• W1630155892 hasAuthorship W1630155892A5050409304 @default.
• W1630155892 hasAuthorship W1630155892A5054524412 @default.
• W1630155892 hasAuthorship W1630155892A5068093752 @default.
• W1630155892 hasAuthorship W1630155892A5074034944 @default.
• W1630155892 hasConcept C150903083 @default.
• W1630155892 hasConcept C170493617 @default.
• W1630155892 hasConcept C185592680 @default.
• W1630155892 hasConcept C202751555 @default.
• W1630155892 hasConcept C203014093 @default.
• W1630155892 hasConcept C207001950 @default.
• W1630155892 hasConcept C2776914184 @default.
• W1630155892 hasConcept C2777209026 @default.
• W1630155892 hasConcept C2778754761 @default.
• W1630155892 hasConcept C49039625 @default.
• W1630155892 hasConcept C55493867 @default.
• W1630155892 hasConcept C86803240 @default.
• W1630155892 hasConcept C98274493 @default.
• W1630155892 hasConceptScore W1630155892C150903083 @default.
• W1630155892 hasConceptScore W1630155892C170493617 @default.
• W1630155892 hasConceptScore W1630155892C185592680 @default.
• W1630155892 hasConceptScore W1630155892C202751555 @default.
• W1630155892 hasConceptScore W1630155892C203014093 @default.
• W1630155892 hasConceptScore W1630155892C207001950 @default.
• W1630155892 hasConceptScore W1630155892C2776914184 @default.
• W1630155892 hasConceptScore W1630155892C2777209026 @default.
• W1630155892 hasConceptScore W1630155892C2778754761 @default.
• W1630155892 hasConceptScore W1630155892C49039625 @default.
• W1630155892 hasConceptScore W1630155892C55493867 @default.
• W1630155892 hasConceptScore W1630155892C86803240 @default.
• W1630155892 hasConceptScore W1630155892C98274493 @default.
• W1630155892 hasFunder F4320321001 @default.
• W1630155892 hasFunder F4320322769 @default.
• W1630155892 hasIssue "2" @default.

• next